Report Detail

Other Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2019-2025

  • RnM2700434
  • |
  • 27 May, 2019
  • |
  • Global
  • |
  • 95 pages
  • |
  • QYResearch
  • |
  • Other

Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Induced Pluripotent Stem Cells Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Hepatocytes
      • 1.4.3 Fibroblasts
      • 1.4.4 Keratinocytes
      • 1.4.5 Amniotic Cells
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Induced Pluripotent Stem Cells Market Share by Application (2014-2025)
      • 1.5.2 Academic Research
      • 1.5.3 Drug Development And Discovery
      • 1.5.4 Toxicity Screening
      • 1.5.5 Regenerative Medicine
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Induced Pluripotent Stem Cells Market Size
    • 2.2 Induced Pluripotent Stem Cells Growth Trends by Regions
      • 2.2.1 Induced Pluripotent Stem Cells Market Size by Regions (2014-2025)
      • 2.2.2 Induced Pluripotent Stem Cells Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Induced Pluripotent Stem Cells Market Size by Manufacturers
      • 3.1.1 Global Induced Pluripotent Stem Cells Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Induced Pluripotent Stem Cells Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Induced Pluripotent Stem Cells Market Concentration Ratio (CR5 and HHI)
    • 3.2 Induced Pluripotent Stem Cells Key Players Head office and Area Served
    • 3.3 Key Players Induced Pluripotent Stem Cells Product/Solution/Service
    • 3.4 Date of Enter into Induced Pluripotent Stem Cells Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Induced Pluripotent Stem Cells Market Size by Type (2014-2019)
    • 4.2 Global Induced Pluripotent Stem Cells Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Induced Pluripotent Stem Cells Market Size (2014-2019)
    • 5.2 Induced Pluripotent Stem Cells Key Players in United States
    • 5.3 United States Induced Pluripotent Stem Cells Market Size by Type
    • 5.4 United States Induced Pluripotent Stem Cells Market Size by Application

    6 Europe

    • 6.1 Europe Induced Pluripotent Stem Cells Market Size (2014-2019)
    • 6.2 Induced Pluripotent Stem Cells Key Players in Europe
    • 6.3 Europe Induced Pluripotent Stem Cells Market Size by Type
    • 6.4 Europe Induced Pluripotent Stem Cells Market Size by Application

    7 China

    • 7.1 China Induced Pluripotent Stem Cells Market Size (2014-2019)
    • 7.2 Induced Pluripotent Stem Cells Key Players in China
    • 7.3 China Induced Pluripotent Stem Cells Market Size by Type
    • 7.4 China Induced Pluripotent Stem Cells Market Size by Application

    8 Japan

    • 8.1 Japan Induced Pluripotent Stem Cells Market Size (2014-2019)
    • 8.2 Induced Pluripotent Stem Cells Key Players in Japan
    • 8.3 Japan Induced Pluripotent Stem Cells Market Size by Type
    • 8.4 Japan Induced Pluripotent Stem Cells Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Induced Pluripotent Stem Cells Market Size (2014-2019)
    • 9.2 Induced Pluripotent Stem Cells Key Players in Southeast Asia
    • 9.3 Southeast Asia Induced Pluripotent Stem Cells Market Size by Type
    • 9.4 Southeast Asia Induced Pluripotent Stem Cells Market Size by Application

    10 India

    • 10.1 India Induced Pluripotent Stem Cells Market Size (2014-2019)
    • 10.2 Induced Pluripotent Stem Cells Key Players in India
    • 10.3 India Induced Pluripotent Stem Cells Market Size by Type
    • 10.4 India Induced Pluripotent Stem Cells Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Induced Pluripotent Stem Cells Market Size (2014-2019)
    • 11.2 Induced Pluripotent Stem Cells Key Players in Central & South America
    • 11.3 Central & South America Induced Pluripotent Stem Cells Market Size by Type
    • 11.4 Central & South America Induced Pluripotent Stem Cells Market Size by Application

    12 International Players Profiles

    • 12.1 Fujifilm Holding Corporation
      • 12.1.1 Fujifilm Holding Corporation Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Induced Pluripotent Stem Cells Introduction
      • 12.1.4 Fujifilm Holding Corporation Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
      • 12.1.5 Fujifilm Holding Corporation Recent Development
    • 12.2 Astellas Pharma
      • 12.2.1 Astellas Pharma Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Induced Pluripotent Stem Cells Introduction
      • 12.2.4 Astellas Pharma Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
      • 12.2.5 Astellas Pharma Recent Development
    • 12.3 Fate Therapeutics
      • 12.3.1 Fate Therapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Induced Pluripotent Stem Cells Introduction
      • 12.3.4 Fate Therapeutics Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
      • 12.3.5 Fate Therapeutics Recent Development
    • 12.4 Bristol-Myers Squibb Company
      • 12.4.1 Bristol-Myers Squibb Company Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Induced Pluripotent Stem Cells Introduction
      • 12.4.4 Bristol-Myers Squibb Company Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
      • 12.4.5 Bristol-Myers Squibb Company Recent Development
    • 12.5 ViaCyte
      • 12.5.1 ViaCyte Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Induced Pluripotent Stem Cells Introduction
      • 12.5.4 ViaCyte Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
      • 12.5.5 ViaCyte Recent Development
    • 12.6 Celgene Corporation
      • 12.6.1 Celgene Corporation Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Induced Pluripotent Stem Cells Introduction
      • 12.6.4 Celgene Corporation Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
      • 12.6.5 Celgene Corporation Recent Development
    • 12.7 Aastrom Biosciences
      • 12.7.1 Aastrom Biosciences Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Induced Pluripotent Stem Cells Introduction
      • 12.7.4 Aastrom Biosciences Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
      • 12.7.5 Aastrom Biosciences Recent Development
    • 12.8 Acelity Holdings
      • 12.8.1 Acelity Holdings Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Induced Pluripotent Stem Cells Introduction
      • 12.8.4 Acelity Holdings Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
      • 12.8.5 Acelity Holdings Recent Development
    • 12.9 StemCells
      • 12.9.1 StemCells Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Induced Pluripotent Stem Cells Introduction
      • 12.9.4 StemCells Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
      • 12.9.5 StemCells Recent Development
    • 12.10 Japan Tissue Engineering
      • 12.10.1 Japan Tissue Engineering Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Induced Pluripotent Stem Cells Introduction
      • 12.10.4 Japan Tissue Engineering Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
      • 12.10.5 Japan Tissue Engineering Recent Development
    • 12.11 Organogenesis

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Pluripotent stem cells are embryonic stem cells that have the potential to form all adult cell types and help in repairing of damaged tissues in the human body. An induced pluripotent stem cells, or iPSCs, are taken from any tissue (usually skin or blood) from a child or an adult and is genetically modified to behave like pluripotent stem cells or embryonic stem cells.
      iPSCs market is in emerging state mainly due to its ability to make any cell or tissue the body might need to encounter wide range of diseases like diabetes, spinal cord injury, leukaemia or heart disease, these cells can potentially be customized to provide a perfect genetic match for any patient.
      In 2018, the global Induced Pluripotent Stem Cells market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Induced Pluripotent Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells development in United States, Europe and China.

      The key players covered in this study
      Fujifilm Holding Corporation
      Astellas Pharma
      Fate Therapeutics
      Bristol-Myers Squibb Company
      ViaCyte
      Celgene Corporation
      Aastrom Biosciences
      Acelity Holdings
      StemCells
      Japan Tissue Engineering
      Organogenesis

      Market segment by Type, the product can be split into
      Hepatocytes
      Fibroblasts
      Keratinocytes
      Amniotic Cells
      Others

      Market segment by Application, split into
      Academic Research
      Drug Development And Discovery
      Toxicity Screening
      Regenerative Medicine

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Induced Pluripotent Stem Cells status, future forecast, growth opportunity, key market and key players.
      To present the Induced Pluripotent Stem Cells development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Induced Pluripotent Stem Cells are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Induced Pluripotent Stem Cells . Industry analysis & Market Report on Induced Pluripotent Stem Cells is a syndicated market report, published as Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Induced Pluripotent Stem Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,085.13
      4,627.70
      6,170.27
      3,465.81
      5,198.72
      6,931.63
      422,654.70
      633,982.05
      845,309.40
      271,832.73
      407,749.10
      543,665.46
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report